← Every applicant
Hq Spclt Pharma FDA Approvals
4 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDENew drugFeb 21, 2025SOLUTION, INTRAVENOUS |
| MEROPENEMNew drugJul 26, 2023POWDER, INTRAVENOUS |
| CEFAZOLIN SODIUMNew drugMay 8, 2023POWDER, INTRAVENOUS |
| ESMOLOL HYDROCHLORIDENew drugDec 2, 2022INJECTABLE, INJECTION |